- Report
- February 2024
- 120 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- April 2023
- 105 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- June 2022
- 120 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- June 2022
- 115 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- January 2022
- 120 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- February 2024
- 200 Pages
Global
From €7065EUR$7,500USD£6,041GBP
- Report
- January 2024
- 120 Pages
Global
From €7489EUR$7,950USD£6,404GBP
- Report
- May 2023
- 450 Pages
Global
From €4710EUR$5,000USD£4,027GBP
- Report
- April 2023
- 399 Pages
Global
From €8949EUR$9,500USD£7,652GBP
- Report
- January 2022
- 60 Pages
Global
From €3721EUR$3,950USD£3,182GBP
- Report
- November 2023
- 77 Pages
France
From €3297EUR$3,500USD£2,819GBP
- Report
- January 2024
- 130 Pages
Global
From €4239EUR$4,500USD£3,625GBP
- Report
- February 2024
- 184 Pages
Global
From €4239EUR$4,500USD£3,625GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3768EUR$4,000USD£3,222GBP
- Report
- December 2023
- 140 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- April 2022
- 120 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- July 2021
- 112 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- March 2023
- 211 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- January 2024
- 95 Pages
Middle East, Africa
From €3250EUR$3,450USD£2,779GBP
- Report
- December 2023
- 150 Pages
Global
From €4192EUR$4,450USD£3,584GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more